PEG Q1 2026 Earnings Utility Giant Beats Estimates as Operational Efficiency Drives Profit SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress TDG Q1 2026 Earnings EPS Surpasses Estimates on Robust Aerospace Demand CHCI Q1 2008 Earnings EPS Misses Estimates Sharply Stock Gains Despite Weakness Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses YUMC Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Operational Resilience